Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype

Journal of General Virology

Volumn 81, Issue 2, 2000, Pages 369-378

  Sobotta, Dirk ^a   Sominskaya, Irina ^b   Jansons, Juris ^b   Meisel, Helga ^c   Schmitt, Sigrid ^a   Heermann, Klaus Hinrich ^d   Kaluza, Georg ^a   Pumpens, Paul ^b   Gerlich, Wolfram H ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b Institute of Innovative Biomedical Technology   (Latvia)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; ENZYME IMMUNOASSAY; EPITOPE MAPPING; FEMALE; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOBLOTTING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; LONCHOCARPUS GLAUCIFOLIUS; MURINAE;

EID: 0033984767     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-2-369     Document Type: Article

References (47)

1. Berting, A., Hahnen, J., Kröger, M. & Gerlich, W. H. (1995). Computeraided studies on the spatial structure of the small hepatitis B surface protein. Intervirology 38, 8-15.
2. Bichko, V., Pushko, P., Dreilina, D., Pumpens, P. & Grens, E. (1985). Subtype ayw variant of hepatitis B virus: DNA primary structure analysis. FEBS Letters 185, 208-212.
3. Bruss, V., Lu, X., Thomssen, R. & Gerlich, W. H. (1994). Posttranslational alterations in transmembrane topology of the hepatitis B virus envelope protein. EMBO Journal 13, 2273-2279.
4. Carman, W. F., Jacyna, M. R., Hadziyannis, S., Karayiannis, P., McGarvey, M. J., Makris, A. & Thomas, H. C. (1989). Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii, 588-591.
5. Couillin, I., Pol, S., Mancini, M., Driss, F., Brechot, C, Tiollais, P. & Michel, M. L. (1999). Specific vaccine therapy in chronic hepatitis B: Induction of T-cell proliferative responses specific for envelope antigens. Journal of Infectious Diseases 180, 15-26.
6. Cupps, T. R., Tibbies, J., Hurni, W. M., Miller, W. J., Ellis, R. W., Milich, D. & Wetter, N. (1993). In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site. Journal of Immunology 15, 3353-3360.
7. Ellis, R. W. (editor) (1991). Hepatitis B Vaccines in Clinical Practice. New York: Marcel Dekker.
8. Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P. & Charnay, P. (1979). Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281, 646-650.
9. Ganem, D. (1991). Hepadnaviridae and their replication. In Fields Virology, 3rd edn, pp. 2703-2737. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
10. Gültekin, H. & Heermann, K. H. (1988). The use of polyvinylidenedifluoride membranes as a general blotting matrix. Analytical Biochemistry 172, 320-329.
11. Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H. & Gerlich, W. H. (1984). Large surface proteins of hepatitis B virus containing the pre-S sequence. Journal of Virology 52, 396-402.
12. Heermann, K. H., Kruse, F., Seifer, M. & Gerlich, W. H. (1987). Immunogenicity of the gene S and pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28, 14-25.
13. Heermann, K. H., Waldeck, F. & Gerlich, W. H. (1988). Interaction between native human serum and the preS2 domain of hepatitis B virus surface antigen. In Viral Hepatitis and Liver Disease, pp. 697-700. Edited by A. J. Zuckerman. New York: Alan R. Liss.
14. Howard, C. R., Frew, A. F., D'Mello, F. & Stirk, H. (1991). Structure of HBV preS protein predicted by peptide scanning and computer modeling. In Viral Hepatitis and Liver Disease, pp. 254-257. Edited by F. Blaine Hollinger, S. Lemon & H. Margolis. Baltimore: Williams & Wilkins.
15. ltoh, Y., Takai, E., Ohnuma, H., Kitajima, K., Tsuda, F., Machida, A., Mishiro, S., Nakamura, T., Miyakawa, Y. & Mayumi, M. (1986). A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proceedings of the National Academy of Sciences, USA 83, 9174-9178.
16. Janowicz, Z. A., Melber, K., Merckelbach, A., Jacobs, E., Harford, N., Comberbach, M. & Hollerberg, C. P. (1991). Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha. Yeast 7, 431-443.
17. Kann, M. & Gerlich, W. H. (1998). Hepadnaviridae structure and molecular virology. In Viral Hepatitis, 2nd edn, chapter 7. Edited by A. J. Zuckermann & K. C. Thomas. New York: Churchill-Livingstone.
18. Köchel, H. G., Schüler, A., Lottmann, S. & Thomssen, R. (1990). Sequence of cloned hepatitis B virus DNA isolate 991. EMBL accession number X51790.
19. Köhler, G. & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
20. Köhler, G., Hengartner, H. & Shulman, M. J. (1978). Immunoglobulin production by lymphocyte hybridomas. European Journal of Immunology 8, 82-88.
21. Krone, B., Lenz, A., Heermann, K. H., Seifer, M., Lu, X. & Gerlich, W. H. (1990). Interaction between hepatitis B surface proteins and monomeric human serum albumin. Hepatology 11, 1050-1056.
22. Legler, K., Strohmeyer H., Ritter, S., Gerlich, W. H. & Thomssen, R. (1983). Kinetics, subtype specificity and immunoglobulin class of anti-HBs induced by hepatitis B vaccine. Developments in Biological Standardization 54, 179-198.
23. Machida, A., Kishimoto, S., Ohnuma, H., Baba, K., Ito, Y., Miyamoto, H., Funatsu, G., Oda, K., Usuda, S., Togami, S., Nakamura, T., Miyakawa, Y. & Mayumi, M. (1984). A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxy-ribonucleotide acid bears the receptor of polymerized human as well as chimpanzee albumins. Gastroenterology 86, 910-918.
24. Magnius, L. O. & Norder, H. (1995). Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38, 24-34.
25. Meisel, H., Jantschak, J., Tars, K., Prosch, S., Pushko, P. & Pumpens, P. (1993). Complete nucleotide sequence of hepatitis B virus, subtype adw. EMBL accession number L13994.
26. Meisel, H., Sominskaya, I., Pumpens, P., Pushko, P., Boriskova, G., Deepen, R., Lu, X., Spiller, G., Krüger, D., Grens, E. & Gerlich, W. H. (1994). Fine mapping and functional characterization of two immunodominant regions from the preS2 sequence of hepatitis B virus. lntervirology 37, 330-339.
27. Milich, D. R. (1997). Pathobiology of acute and chronic hepatitis B virus infection: an introduction. Journal of Viral Hepatology 4, 25-30.
28. Milich, D. R., Thornton, G. B., Neurath, A. R., Kent, S. B., Michel, M. L., Tiollais, P. & Chisari, F. V. ( 1985). Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228, 1195-1199.
29. Milich, D. R., McLachlan, A., Chisari, L. V., Nakamura, T. & Thornton, G. B. (1987). Two distinct but overlapping antibody binding sites in the preS2 region of HBsAg localized within 11 continuous residues. Journal of Immunology 137, 2703-2710.
30. Mimms, L. T., Floreani, M., Tyner, J. & Whitters, E. (1990). Discrimination of hepatitis B virus subtypes using monoclonal antibodies to the preS1 and preS2 domains of the viral envelope. Virology 176, 604-619.
31. Miskovsky, E., Gershman, K., Clements, M. L., Cupps, T., Calandra, G., Hesley, T., Loli, V., Ellis, R., Kniskern, P. & Miller, W. (1991). Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and preS2 + S antigens. Vaccine 9, 346-350.
32. Naumann, H., Schaefer, S., Yoshida, C. F. T., Gaspar, A. M. C., Repp, R. & Gerlich, W. H. (1993). Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. Journal of General Virology 74, 1627-1632.
33. Neurath, A. R. & Kent, S. B. H. (1988). The pre-S region of hepadnavirus envelope proteins. Advances in Virus Research 34, 65-69.
34. Neurath, A. R., Kent, S. B. H. & Strick, N. (1984). Localisation and chemical synthesis of a preS gene coded immunodominant epitope of hepatitis B virus. Science 224, 392-395.
35. Neurath, A. R., Kent, S. B., Parker, K., Prince, A. M., Strick, N., Brotman, B. & Sproul, P. (1986a). Antibodies to a synthetic peptide from the pre-S2 120-145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4, 35-37.
36. Neurath, A. R., Kent, S. B. H., Strick, N. & Parker, K. (1986b). Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 429-436.
37. Neurath, A. R., Adamowics, P., Kent, S. B. H., Riottot, M. M., Strick, N., Parker, K., Offensperger, W., Petit, M. A., Wahl, S. & Budkowska, A. (1986c). Characterization of monoclonal antibodies specific for the preS2 region of the hepatitis B envelope protein. Molecular Immunology 23, 991-997.
38. Peterson, D. L., Paul, D. A., Lam, J., Tribby, I. I. & Achord, D. T. (1984). Antigenic structure of hepatitis B surface antigen; identification of the 'd' subtype determinant and use of monoclonal antibodies. Journal of Immunology 132, 920.
39. Pontisso, P., Petit, M. A., Bankowski, M. J. & Peeples, M. E. (1989). Human liver plasma membranes contain receptors for hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. Journal of Virology 63, 1981-1988.
40. Prange, R. & Streeck, R. E. (1995). Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO Journal 14, 247-256.
41. Schmitt, S., Glebe, D., Alving, K., Tolle, T., Linder, M., Linder, D., Peter-Katalinic, J., Gerlich, W. H. & Geyer, R. (1999). Analysis of the preS2 N-and O-glycans of the M surface protein from human hepatitis B virus. Journal of Biological Chemistry 274, 11945-11957.
42. Shouval, D., Ilan, Y., Adler, R., Deepen, R., Panet, A., Even-Chen, Z., Gorecki, M. & Gerlich, W. H. (1994). Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing preS1 and preS2 antigens as compared with conventional yeast-derived vaccines. Vaccine 12, 1453-1459.
43. Sominskaya, I., Bichko, V., Pushko, P., Dreimane, A., Snikere, D. & Pumpens, P. (1992). Tetrapeptide QDPR is a minimal immunodominant epitope within the preS2 domain of hepatitis B virus. Immunology Letters 33, 169-172.
44. Thoma, H. A., Hemmerling, A. E., Koller, E. & Kapfer, G. (1990). Does PreS2 have the same effect in improving he HBV immune response as preS1? In Viral Hepatitis and Liver Disease, pp. 736-744. Edited by F. Blaine Hollinger, S. Lemon & H. Margolis. Baltimore: Williams & Wilkins.
45. Tolle, T., Glebe, D., Linder, M., Linder, D., Schmitt, S., Geyer, R. & Gerlich, W. H. (1998). Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus. Journal of Virology 72, 9978-9985.
46. Valenzuela, P., Quiroga, M., Zaldivar, J., Gray, P. & Rutter, W. J. (1981). The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In Animal Virus Genetics, pp. 57-70. Edited by B. N. Fields, R. Jaenisch & C. F. Fox. New York: Academic Press.
47. Yu, M. W., Finlayson, J. S. & Shih, J. W. (1985). Interaction between various polymerized human albumins and hepatitis B surface antigen. Journal of Virology 55, 736-743.